ATE23169T1 - Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik. - Google Patents

Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik.

Info

Publication number
ATE23169T1
ATE23169T1 AT84304747T AT84304747T ATE23169T1 AT E23169 T1 ATE23169 T1 AT E23169T1 AT 84304747 T AT84304747 T AT 84304747T AT 84304747 T AT84304747 T AT 84304747T AT E23169 T1 ATE23169 T1 AT E23169T1
Authority
AT
Austria
Prior art keywords
proteinoid
diagnostics
receptors
brain
synthetic polypeptides
Prior art date
Application number
AT84304747T
Other languages
English (en)
Inventor
J Gregor Sutcliffe
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE23169T1 publication Critical patent/ATE23169T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84304747T 1983-07-21 1984-07-11 Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik. ATE23169T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51613683A 1983-07-21 1983-07-21
EP84304747A EP0135277B1 (de) 1983-07-21 1984-07-11 Synthetische Polypeptide, die gehirnspezifischen mRNAs translatierten Proteinoidabschnitten entsprechen, sowie ihre Anwendung für Rezeptoren, Methoden und Diagnostik

Publications (1)

Publication Number Publication Date
ATE23169T1 true ATE23169T1 (de) 1986-11-15

Family

ID=24054282

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84304747T ATE23169T1 (de) 1983-07-21 1984-07-11 Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik.

Country Status (9)

Country Link
EP (1) EP0135277B1 (de)
JP (1) JPS60190796A (de)
KR (1) KR850000920A (de)
AT (1) ATE23169T1 (de)
AU (1) AU576508B2 (de)
CA (1) CA1247521A (de)
DE (1) DE3461093D1 (de)
ES (1) ES8507612A1 (de)
PH (2) PH21409A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
DE3650676T2 (de) * 1985-08-28 1998-09-17 George Pieczenik Verfahren und mittel zur sortierung und bestimmung biologischer informationen
EP0297585A3 (de) * 1987-07-01 1990-05-23 Sloan-Kettering Institute For Cancer Research Neuronales Polypeptid und Verfahren zu seiner Herstellung und Verwendung
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
WO1997010507A1 (en) * 1995-09-11 1997-03-20 La Jolla Cancer Research Foundation Molecules that home to a selected organ or tissue in vivo and methods of identifying same
US6743892B1 (en) 1995-09-11 2004-06-01 La Jolla Cancer Research Foundation Molecules that home to a selected organ in vivo
US6576239B1 (en) 1996-09-10 2003-06-10 The Burnham Institute Angiogenic homing molecules and conjugates derived therefrom
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
US7544767B2 (en) 2002-04-05 2009-06-09 Burnham Institute For Medical Research HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
US8176811B2 (en) * 2004-07-30 2012-05-15 Dana Heavy Vehicle Systems Group, Llc Ribbed cover for drive axle housing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949064A (en) * 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
US4205057A (en) * 1978-01-17 1980-05-27 Government Of The United States Cerebrospinal fluid protein fragments

Also Published As

Publication number Publication date
KR850000920A (ko) 1985-03-14
JPS60190796A (ja) 1985-09-28
PH21409A (en) 1987-10-15
AU576508B2 (en) 1988-09-01
AU3081384A (en) 1985-01-24
CA1247521A (en) 1988-12-28
PH22909A (en) 1989-01-24
EP0135277B1 (de) 1986-10-29
ES534510A0 (es) 1985-09-16
ES8507612A1 (es) 1985-09-16
EP0135277A1 (de) 1985-03-27
DE3461093D1 (en) 1986-12-04

Similar Documents

Publication Publication Date Title
ATE23169T1 (de) Synthetische polypeptide, die gehirnspezifischen mrnas translatierten proteinoidabschnitten entsprechen, sowie ihre anwendung fuer rezeptoren, methoden und diagnostik.
DK1026239T3 (da) Ny fremgangsmåde til at udnytte det immunologiske repertoire
DE3881801D1 (de) Menschliche somatomedin-traeger-protein-untereinheiten und verfahren zu ihrer herstellung.
ATE296315T1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
ATE181993T1 (de) Durch ein nassverfahren hergestelltes reibungsmaterial und verfahren zu seinen herstellung
DE69000125D1 (de) Verfahren zum verbinden von elementen zur herstellung von teilen aus mehrstrukturellem verbundmaterial.
EP0775750A3 (de) Herstellung von Proteinen aus Pro-Proteinen durch Fusionsproteine abgeleitet von Furin oder Furinanalogen
SE0000855D0 (sv) Antigenic composition useful as a vaccine against atherosclerosis
IL122233A0 (en) Monoclonal antibodies their production and pharmaceutical compositions and diagnostic reagents containing them
ATE186781T1 (de) Verfahren zur herstellung von testelementen
DE69737651D1 (de) Cortistatin: neuropeptide, zusammensetzungen und methoden
DE59001070D1 (de) Fluessiges treibstoffgemisch, verfahren zu seiner herstellung und seine verwendung fuer zweitaktmotoren.
DE69031726T2 (de) Antikörper, ihre Herstellung und Verwendung
ATE466893T1 (de) Zusammensetzung und verfahren zum selektiven anbinden von aminen oder aminosäure-enantiomeren an ihre gegen-enantiomere
ATE216778T1 (de) Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein
EA200000413A1 (ru) Способ синтеза пирроламидов
DE69935785D1 (de) Substitutierte aminosaeuren als erythropoietin-mimetica
ATE190060T1 (de) Naphthyridinium-derivat, verfahren zu seiner herstellung, antikörper gegen dieses derivat und die verwendung dieses antikörpers
CA2225198C (en) Method for the synthesis of deoxypyridinoline
EP0338436A3 (de) Monoklonale Antikörper gegen das Neuropeptid Y, Verfahren zu ihrer Herstellung sowie ihre Verwendung
ATE137497T1 (de) Verbindungen aus biopolymeren und effektorsubstanzen, die über optisch aktive aminosäurederivaten verknüpft sind, verfahren zu ihrer herstellung und ihre verwendung
ATE239754T1 (de) An nukleinsäure gebundenes polypeptid, verfahren zur herstellung eines an nukleinsäure gebundenen polypeptides und immunoassay, in dem dieses polypeptid verwendung findet
EP0810202A3 (de) Verfahren zur Herstellung von 4-Oxa-Aminen
DE59803365D1 (de) S-(4-biphenyl)-thioschwefelsäuren und ihre salze, verfahren zu deren herstellung und die herstellung von 4-mercaptobiphenylen
DE19737454A1 (de) Arzneimittel-Carrier-Konjugate, Verfahren zu ihrer Herstellung und ihre Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee